MapLight Therapeutics, Inc. Common Stock (MPLT) — Financial Flexibility Index
MapLight Therapeutics, Inc. Common Stock (MPLT) has a Financial Flexibility Index of -2.20x as of December 2025. Free cash flow of $-46.45 Million (operating CF $-46.83 Million minus capex $376.00K) represents -2% of total liabilities ($21.14 Million). Check asset allocation strategy of MapLight Therapeutics, Inc. Common Stock to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
MapLight Therapeutics, Inc. Common Stock Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for MapLight Therapeutics, Inc. Common Stock across 4 annual periods. See working capital position of MapLight Therapeutics, Inc. Common Stock to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for MapLight Therapeutics, Inc. Common Stock (2022–2025)
Year-by-year free cash flow to debt coverage for MapLight Therapeutics, Inc. Common Stock. For the full company profile including market capitalisation, see MapLight Therapeutics, Inc. Common Stock (MPLT) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -6.51x | $-137.66 Million | $-138.14 Million | $21.14 Million | ▼ -81.2% |
| 2024 | -3.59x | $-78.05 Million | $-78.81 Million | $21.72 Million | ▼ -40.3% |
| 2023 | -2.56x | $-51.54 Million | $-52.01 Million | $20.13 Million | ▼ -83.6% |
| 2022 | -1.39x | $-25.83 Million | $-26.58 Million | $18.52 Million | — |